Industry Insights
-
Trends Shaping The Pharmaceutical Industry's Future
4/10/2024
Decentralized trials and patient choice are key to expanding clinical trial reach. Through diverse options and AI-powered connections across health systems and community sites, learn how patient access increases.
-
Something To Believe In — AI And Accelerated Computing In Healthcare
4/10/2024
See how the advancements in supercomputing, high-performance networking, and cloud technology are paving the way for unprecedented levels of innovation and creativity in this field.
-
ICH E6(R3) And Defining What Is Critical To TMF Quality
4/9/2024
By applying Quality by Design to clinical trials, sponsor companies can rise to meet the elevated role and importance of the TMF in the face of ICH E6 (RF3).
-
2024 CIO Survey Reveals IT Budgets, AI Priorities For Life Sciences Companies
4/9/2024
Clarkston Consulting conducted its third annual Chief Information Officer (CIO) Survey to understand IT budgets of life sciences companies, how AI priorities fit into those budgets, and more.
-
Insights Into The Clinical Trials Landscape Of CL
4/8/2024
Uncover developments in cystic fibrosis treatment, focusing on innovative drugs, ongoing clinical trials, and their potential impact on patient outcomes.
-
Global Prevalence And Clinical Trials Landscape Of AML
4/8/2024
Explore the advancements in Acute Myeloid Leukaemia treatments, specifically innovative drugs, ongoing clinical trials, and their potential impact on patient outcomes.
-
Mobile Visits Are Key To Decentralizing Rare Disease Research
4/8/2024
Discover how mobile visits revolutionize rare disease research, bridging gaps in clinical trial accessibility and enhancing patient engagement for conditions like Rett Syndrome.
-
Can Mobile Visits Attract And Keep More Children In Clinical Trials?
4/8/2024
As sponsors face regulatory pressure to include more pediatric patients in trials, could mobile nurse visits help them enroll more patients from this underrepresented group?
-
Comprehensive Data Management For Non-Interventional Research
4/8/2024
Learn how your teams can embrace end-to-end clinical trial data platforms for non-interventional studies to improve user experience, boost patient engagement, ensure data quality, and achieve study success.
-
AI And Pharmaceutical Development: WHO Calls For Ethical Framework, Good Governance
4/8/2024
The World Health Organization (WHO) recently released a document titled Benefits and risks of using artificial intelligence for pharmaceutical development and delivery describing the ethical issues and governance considerations for using AI in drug discovery, preclinical development, and clinical trials.